Arix Bioscience Valuation

Is ARIXL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ARIXL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ARIXL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ARIXL's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ARIXL?

Key metric: As ARIXL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ARIXL. This is calculated by dividing ARIXL's market cap by their current earnings.
What is ARIXL's PE Ratio?
PE Ratio	9.5x
Earnings	UK£14.96m
Market Cap	UK£142.02m

ARIXL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.9x
Enterprise Value/EBITDA	4.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does ARIXL's PE Ratio compare to its peers?

The above table shows the PE ratio for ARIXL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	21.9x
RIII Rights and Issues Investment Trust	6.7x	n/a	UK£114.7m
TMT TMT Investments	10.2x	n/a	US$96.2m
SBSI Schroder BSC Social Impact Trust	62x	n/a	UK£65.1m
EJFI EJF Investments	8.7x	n/a	UK£68.5m
ARIXL Arix Bioscience	9.5x	n/a	UK£142.0m

Price-To-Earnings vs Peers: ARIXL is good value based on its Price-To-Earnings Ratio (9.5x) compared to the peer average (32.6x).

Price to Earnings Ratio vs Industry

How does ARIXL's PE Ratio compare vs other companies in the GB Capital Markets Industry?

4 Companies	Price / Earnings	Estimated Growth	Market Cap
PNIX Phoenix Digital Assets	1.2x	n/a	US$34.88m
IX. i(x) Net Zero	0.1x	n/a	US$8.94m
APQ APQ Global	0.4x	n/a	US$5.78m
MAFL Mineral & Financial Investments	2x	n/a	US$5.00m

No more companies available in this PE range

4 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: ARIXL is good value based on its Price-To-Earnings Ratio (9.5x) compared to the UK Capital Markets industry average (14.9x).

Price to Earnings Ratio vs Fair Ratio

What is ARIXL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ARIXL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	9.5x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ARIXL's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Exor

€20.2b

Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.

0RKY

€94.25

0.6%

8.0%

HAL Trust

€10.4b

Operates through multi-sectors in Europe, the United States, Canada, Asia, and internationally.

0K9V

€115.20

0.9%

1.8%

Man Group

UK£2.4b

Man Group Limited is a publicly owned investment manager.

EMGL

UK£2.06

-0.6%

-0.7%